Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multicenter analysis of the Mycoplasma pneumoniae resurgence in China 2023-2024.

Scientific reports - 8 Dec 2025

Zhang Mengyang, Wen Wen, Ma Yanxiu, Hua Yiyuan, Cao Qicong, Lai Haizhen, Ye Guangming, Wu Li, Chen Guomei, Ke Qiang, Sun Xiaoming

Abstract excerpt

Mycoplasma pneumoniae is a significant cause of community-acquired pneumonia, with epidemic peaks occurring every 3–7 years. This multicenter, retrospective study analyzed 421 M. pneumoniae strains from four regions in China (Liaoning, Zhejiang, Wuhan, Guizhou) collected between November 2023 and January 2024, alongside 147 publicly available genomes, to investigate genotypic diversity and macrolide resistance...

Topics

Join the communities discussing this publication.

Anti-Bacterial Agents
China
Drug Resistance, Bacterial
Macrolides
Mycoplasma pneumoniae

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Pneumonia, Mycoplasma

RNA, Ribosomal, 23S

Source

Open in PubMed Open full text

Identifiers

PMID: 41361338
DOI: 10.1038/s41598-025-29135-7
PMCID: PMC12764581

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multicenter analysis of the Mycoplasma pneumoniae resurgence in China 2023-2024.PMID 41361338Read ↗

Genomic epidemiology and antimicrobial susceptibility of clinical Mycoplasma pneumoniae isolates in Shanghai, 2023-2024.Semantic proximity Read ↗

Increased in vitro antimicrobial resistance of Mycoplasma pneumoniae isolates obtained from children in Beijing, China, in 2023.Semantic proximity Read ↗

Genetic factors driving the Mycoplasma pneumoniae outbreak among children post-COVID-19 in China: a whole genome analysisSemantic proximity Read ↗

Molecular epidemiology of Mycoplasma pneumoniae pneumonia in children, Wuhan, 2020-2022Semantic proximity Read ↗

Epidemiology and high-level macrolide resistance of Mycoplasma pneumoniae among children in Hangzhou, China: a 2024–2025 single-center surveillance studySemantic proximity Read ↗

Epidemiology, Co-infections, and Macrolide Resistance of Mycoplasma pneumoniae infection in Hangzhou, China: A Multicenter Study AnalysisSemantic proximity Read ↗

Molecular epidemiology of Mycoplasma pneumoniae pneumonia in children, Wuhan, 2020–2022Semantic proximity Read ↗

Multiplex amplicon sequencing reveals polyclonality and low macrolide resistance in the French Mycoplasma pneumoniae outbreak, 2023-2024.Semantic proximity Read ↗

Macrolide resistance mutations of Mycoplasma pneumoniae in children and adults in Yunnan and its correlation with P1 genotype.Semantic proximity Read ↗

Molecular epidemiology and genomic characterization of postpandemic macrolide-resistant Mycoplasma pneumoniae in hospitalized children.Semantic proximity Read ↗

Macrolide resistance and risk factors for refractory Mycoplasma pneumoniae pneumonia in pediatric patients from Wuhu, China: A retrospective cohort study.Semantic proximity Read ↗

Genomic epidemiological analysis reveals new insights into the resurgence of Mycoplasma pneumoniae in ChinaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.